Cost Cutting, Capital Crunch Could Devastate Biotech
Research Recap submits: Cost cutting and the continuing capital crunch are likely to damage the life sciences industries, with a potentially devastating effect on the biotech sector, according to a new paper from Deloitte and the Economist Intelligence Unit. The paper, The Future of Life Sciences Industries: Aftermath of the global recession,” is based on an online survey of 281 senior industry executives during Fall 2009. The report sought to assess the short- and long-term impact of the global recession on the life sciences industries.Complete Story » seekingalpha.com |
U.S. Tan Tax Burns Some Badly
A tax on tanning services will be the first tax to take effect in the health-care overhaul. But not all tans are taxed. Those offered by health-care clubs often aren't, and spray tans aren't. online.wsj.com |
Genzyme Catches Eye of Others
Sanofi-Aventis may not be the only big drug maker interested in Genzyme, after news of Sanofi's interest in the U.S. biotech company became public. online.wsj.com |
Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development
[PR Newswire] - Spherix Incorporated , an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that the Company's pharmaceutical product, D-tagatose, has been selected as one of the top 10 most promising cardiovascular/metabolic therapies in development. Â The selection was made by an independent committee assembled by Windhover Information, a leading provider of business information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries and publisher of IN VIVO and Start-Up. Â Spherix has been invited to present its data on D-tagatose at Windhover's Therapeutic Alliances Cardiovascular Conference in Boston on November 3-4, 2010. us.rd.yahoo.com |
Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2010 Financial Results Conference Call
[PR Newswire] - In conjunction with its third quarter 2010 earnings release , Covance Inc. is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, November 4th, 2010 at 9:00 a.m. us.rd.yahoo.com |